The Food and Drug Administration (FDA) is an HHS agency that regulates clinical investigations of products under its jurisdiction, such as drugs, biological products, and medical devices.
The grant's broad goal is to support meetings that involve a wide range of stakeholders to discuss, explore, and research issues related to medical products, policy, and surveillance methods and systems. This includes not only the design and planning of these discussions but also the execution, synthesis, summary, and dissemination of their findings. The aim is to foster a comprehensive exploration of these topics among experts and relevant parties, ensuring the findings reach a diverse audience.